Director at IDEX (NYSE: IEX) receives 805 RSUs vesting in 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Watts Stanfield Paris reported acquisition or exercise transactions in this Form 4 filing.

IDEX CORP director Stanfield Paris Watts received an equity award of 805 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of IDEX common stock. Following this grant, the director holds 4,195 shares of common stock.

The RSUs vest in full on the earlier of May 6, 2027, or the date of IDEX’s next annual stockholders meeting, if that meeting occurs at least 50 weeks after the prior year’s meeting. Vesting is conditioned on the director’s continuous service through the vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Watts Stanfield Paris

Role null

Type	Security	Shares	Price	Value
Grant/Award	COMMON STOCK	805	$0.00	--

Holdings After Transaction: COMMON STOCK — 4,195 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 805 units Price per share: $0.0000 per share Shares after transaction: 4,195 shares +2 more

5 metrics

RSUs granted 805 units Equity award to director on May 6, 2026

Price per share $0.0000 per share Reported grant price for RSU-related common stock

Shares after transaction 4,195 shares Director’s direct common stock holdings following grant

RSU vesting date May 6, 2027 Latest potential vesting date for the RSUs

Alternate vest trigger Next annual meeting If held at least 50 weeks after prior year’s meeting

Key Terms

restricted stock units, contingent right, vest in full, annual stockholders meeting, +1 more

5 terms

restricted stock units financial

"Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

vest in full financial

"These RSUs vest in full on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting"

annual stockholders meeting financial

"on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting"

continuous service financial

"subject to the Reporting Person's continuous service through such date."

Form 4 Insider Transactions: What Each Field Means →

05/08/2026 - 04:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Watts Stanfield Paris

(Last)

(First)

(Middle)

3100 SANDERS ROAD

SUITE 301

(Street)

NORTHBROOK

ILLINOIS

60062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
COMMON STOCK	05/06/2026		A		805⁽¹⁾	A	$0	4,195	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting if it is at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continuous service through such date.

	/s/ Sam Rayburn, by Power of Attorney	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did IDEX (IEX) report for director Stanfield Paris Watts?

IDEX reported that director Stanfield Paris Watts received 805 restricted stock units as an equity award. These RSUs are compensation, not an open-market share purchase, and increase his direct common stock holdings to 4,195 shares after the grant.

How many RSUs were granted in the latest IDEX (IEX) Form 4 filing?

The filing shows a grant of 805 restricted stock units to the reporting director. Each RSU represents a contingent right to receive one share of IDEX common stock, subject to meeting the specified vesting conditions described in the disclosure.

When do the newly granted IDEX (IEX) RSUs vest for the director?

The RSUs vest in full on the earlier of May 6, 2027, or the date of IDEX’s next annual stockholders meeting, provided that meeting is at least 50 weeks after the prior year’s meeting and the director remains in continuous service until that vesting date.

Is the IDEX (IEX) director’s RSU grant an open-market stock purchase?

No, the RSU grant is a compensation award, not an open-market purchase. The director receives 805 restricted stock units at no cash cost per share, which may convert into common stock if the vesting conditions are satisfied over time.

How many IDEX (IEX) shares does the director hold after this RSU award?

After the RSU award, the Form 4 reports that the director beneficially owns 4,195 shares of IDEX common stock directly. This figure reflects his holdings immediately following the 805-unit restricted stock grant described in the insider transaction.

What does each IDEX (IEX) restricted stock unit represent in this Form 4?

Each restricted stock unit represents a contingent right to receive one share of IDEX common stock. Delivery of those shares depends on the RSUs vesting, which requires the director’s continuous service through the specified vesting date described in the grant terms.